Plain-English translation of NCT06278207 on ClinicalTrials.gov ↗ ·
This study watches how finerenone works for people like you who have both chronic kidney disease and type 2 diabetes. Instead of asking you to do anything special, researchers will look at your existing medical records and health data that you're already sharing with your doctor. The goal is to understand how safe and helpful this medication is when used by real patients in everyday life.
Finerenone was recently approved by the FDA to protect kidneys in people with both kidney disease and type 2 diabetes, but doctors need more information about how well it actually works and how safe it is when many different patients use it over time in real life.
You likely qualify if…
You likely don't qualify if…
You won't need to do anything special or visit the clinic more often than you normally would. Researchers will simply collect information from your existing medical records and insurance claims data to see how you're doing on the medication over time. There are no required study visits or extra tests — they're just observing and recording what's already happening in your regular care.
AI-generated summary from trial data · Jun 22, 2026 · Not medical advice
United States
Germany
Japan
Taiwan